Autres langues Implantica AG

Actions

IMP A SDB

SE0014855029

Temps Différé Nasdaq Stockholm Autres places de cotation 16:14:17 14/05/2024			Varia. 5j.	Varia. 1 janv.
27,3 ^SEK	+0,55 %		+2,25 %	+14,23 %

27/03	Implantica soumet le premier module de sa demande d'autorisation de pré-commercialisation auprès de la FDA américaine pour son dispositif médical de traitement du reflux gastro-œsophagien	MT
27/03	Implantica dépose auprès de la FDA américaine une demande d'autorisation préalable de mise sur le marché (PMA) pour RefluxStop® (premier module)	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Tranche Update on Implantica AG (OM:IMP A SDB)'s Equity Buyback Plan announced on April 6, 2023.	26/04
Implantica Submits Initial Module of US FDA Premarket Approval Application for GERD Medical Device	27/03
Implantica Submits U.S. FDA Premarket Approval Application for RefluxStop® (first module)	27/03
Implantica Completes Human Factors Validation Study for RefluxStop as Part of the US FDA Premarket Approval Process	26/03
Implantica to Deploy GERD Treatment in Spain	19/03
Implantica AG (publ.) Wins Another RefluxStop Public Tender in Europe with Hospital Universitario De Getafe	19/03
Implantica AG (OM:IMP A SDB) acquired IRCCS Saverio De Bellis.	05/03
Implantica AG Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	16/02
Implantica Announces Completion of its First RefluxStop Procedures at Artemed Klinikum München Süd in Munich, Germany	15/02
Implantica Announces First Refluxstop Public Tender Win, Paving the Way for Permanent Reimbursement in Italy	13/02
Implantica Ag Announces the First RefluxStop Procedures Completed At MIC Hospital in Berlin	06/02
Implantica AG (publ.) Adds Another RefluxStop Center in Spain	18/12
Implantica AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	22/11
Implantica AG (publ.)'s RefluxStop Offers for the First Time in the NHS in UK	21/11
Implantica Wins EU Medical Device Certifications	07/09/23
Implantica AG Receives MDR Certification for RefluxStop?	07/09/23
Implantica AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24/08/23
Implantica AG Further Expands Its Commercial Footprint in Italy	29/06/23
Implantica AG Announces RefluxStop Results Were Presented At the DDW Conference in Chicago	16/05/23
Tranche Update on Implantica AG (OM:IMP A SDB)'s Equity Buyback Plan announced on April 6, 2023.	12/05/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Implantica AG

Actions

IMP A SDB

SE0014855029

Autres langues

Filtres